Applications of small molecule mimetic drugs that target protein kinases involve not only neurological diseases, but also a variety of other disorders including obesity, metabolic syndrome, muscular degenerations, ulcerative lesions, diabetes, and cancer [42], [60]. This evidence concerns the gene WEE1 and obesity due to melanocortin 4 receptor deficiency.